Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_014845.6(FIG4):c.547C>T(p.Arg183Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000261 in 1,612,104 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
FIG4 (HGNC:16873): (FIG4 phosphoinositide 5-phosphatase) The protein encoded by this gene belongs to the SAC domain-containing protein gene family. The SAC domain, approximately 400 amino acids in length and consisting of seven conserved motifs, has been shown to possess phosphoinositide phosphatase activity. The yeast homolog, Sac1p, is involved in the regulation of various phosphoinositides, and affects diverse cellular functions such as actin cytoskeleton organization, Golgi function, and maintenance of vacuole morphology. Membrane-bound phosphoinositides function as signaling molecules and play a key role in vesicle trafficking in eukaryotic cells. Mutations in this gene have been associated with Charcot-Marie-Tooth disease, type 4J. [provided by RefSeq, Jul 2008]
Verdict is Pathogenic. Variant got 16 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PP5
Variant 6-109735199-C-T is Pathogenic according to our data. Variant chr6-109735199-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 1723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-109735199-C-T is described in Lovd as [Pathogenic].
Charcot-Marie-Tooth disease type 4J Pathogenic:2Uncertain:1
Uncertain significance, no assertion criteria provided
literature only
Inherited Neuropathy Consortium Ii, University Of Miami
Jan 06, 2016
- -
Pathogenic, no assertion criteria provided
literature only
OMIM
Jul 05, 2007
- -
Pathogenic, criteria provided, single submitter
clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Apr 15, 2024
Variant summary: FIG4 c.547C>T (p.Arg183X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 2.8e-05 in 250950 control chromosomes (gnomAD). c.547C>T has been reported in the literature in individuals affected with Charcot-Marie Disease Type 4J (example: Chow_2007). The following publication has been ascertained in the context of this evaluation (PMID: 17572665). ClinVar contains an entry for this variant (Variation ID: 1723). Based on the evidence outlined above, the variant was classified as pathogenic. -
Amyotrophic lateral sclerosis type 11 Pathogenic:1
Pathogenic, no assertion criteria provided
literature only
OMIM
Jan 01, 2009
- -
Amyotrophic lateral sclerosis Pathogenic:1
Likely pathogenic, criteria provided, single submitter
research
Suna and Inan Kirac Foundation Neurodegeneration Research Laboratory, Koc University
Mar 31, 2020
- -
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter
clinical testing
GeneDx
Jun 17, 2015
The R183X nonsense variant in the FIG4 gene has been reported previously in association with CMT4J (Chow et al., 2007). Heterozygosity for the R183X mutation is also reported to be a risk factor for developing amyotrophic lateral sclerosis (ALS) (Chow et al., 2009). This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. -
FIG4-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided
clinical testing
PreventionGenetics, part of Exact Sciences
Jan 03, 2024
The FIG4 c.547C>T variant is predicted to result in premature protein termination (p.Arg183*). This variant has been reported in the compound heterozygous state in siblings with Charcot-Marie-Tooth disease type 4J (Fig. 4b, Chow et al. 2007. PubMed ID: 17572665). It has also been reported in an individual with amyotrophic lateral sclerosis (Table A5, Tunca et al. 2020. PubMed ID: 32579787). This variant is reported in 0.0044% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Nonsense variants in FIG4 are expected to be pathogenic. This variant is interpreted as pathogenic for autosomal recessive Charcot-Marie-Tooth disease type 4J. -
Charcot-Marie-Tooth disease type 4 Pathogenic:1
Pathogenic, criteria provided, single submitter
clinical testing
Labcorp Genetics (formerly Invitae), Labcorp
Jun 05, 2023
For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1723). This variant is also known as c.718C>T. This premature translational stop signal has been observed in individual(s) with Charcot-Marie-Tooth disease, type 4 (PMID: 17572665). This variant is present in population databases (rs121908288, gnomAD 0.005%). This sequence change creates a premature translational stop signal (p.Arg183*) in the FIG4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FIG4 are known to be pathogenic (PMID: 23623387, 30740813). -